Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 691 AL 705

Phytocannabinoid cannabidiol (CBD) in neurodegenerative diseases: From polypharmacology to drug development

Zhang B, Nan J, Zhang Y, Zhang B, Ke C, Wang W, Wu T, Xia J, Yang F, He M, Tian L, Yang Z, Liang C.

Eur J Med Chem. 2026 Sep 23;320:119360. doi: 10.1016/j.ejmech.2026.119360. Online ahead of print.

Revealing the Mechanisms of Alzheimer's, Parkinson's and Huntington's Diseases Through Invertebrate Models

Ding X, Wang P, Zhou L, Li X.

Biology (Basel). 2026 Aug 10;15(16):1351. doi: 10.3390/biology15161351.

Theranostic Innovative Strategies for Brain Diseases: New Insights on Neurovascular Unit-Associated Pathological Changes in Neurodegenerative Disorders and Aging

Terribile G, Pedrinazzi M, Frigerio I, Sancini G, Combi R.

Int J Mol Sci. 2026 Aug 11;27(16):7165. doi: 10.3390/ijms27167165.

Quercetin as a Hypothesized Involvement of VMAT2 in Neurodegenerative Diseases-Mechanistic Insight and Therapeutic Applications

Sharma K, Vikram V, Jamwal P, Bhaumik S, Prasad N, Rohit, Juneja R.

Mol Neurobiol. 2026 Aug 28;63(1):862. doi: 10.1007/s12035-026-06164-5.

Mechanism and progress of deep brain stimulation in the treatment of neurological and psychiatric disorders

Yuan Y, Liu P, Yin C, Zhu J, Xu J, Xiong H, Xu R.

MedScience. 2026 Aug 29. doi: 10.1007/s11684-026-1231-1. Online ahead of print.

Microbiota-derived metabolite-GPCR signalling in neurodegeneration

Sharma A, Jatana N.

Neuroscience. 2026 Sep 4;615:312-333. doi: 10.1016/j.neuroscience.2026.09.001. Online ahead of print.

SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential

Duan J, Liu J, Meng Q, Liu J, Yang S, Zhou F, Cao J.

FASEB J. 2026 Sep 15;40(17):e72288. doi: 10.1096/fj.202602361RR.

Opto-CRISPR technologies in translational neuropharmacology

Lau CH, Xia Q, Liang Q, Guo R, Zhu H.

Neuropharmacology. 2026 Sep 9;301:111185. doi: 10.1016/j.neuropharm.2026.111185. Online ahead of print.

Herbal nanoparticles in the treatment of neurodegeneration: from molecular mechanisms to therapeutic translation

Mittal D, Solanki P, Jain GK, Jhawat V, Kesharwani P, Dutt R, Arora S, Singh RP.

3 Biotech. 2026 Oct;16(10):420. doi: 10.1007/s13205-026-05048-8. Epub 2026 Sep 9.

Mitochondrial Complex V Dysfunction in Neurodegeneration: Secondary Bystander or Primary Driver?

Harris KE, Lascaratos G, Chau KY.

Brain Sci. 2026 Aug 20;16(8):890. doi: 10.3390/brainsci16080890.

Glutathione Biology in Neurodegenerative and Metabolic Diseases: Molecular Mechanisms, Pathophysiological Roles, and Therapeutic Perspectives

Gromadzka G, Kąkol M, Klimkiewicz M, Bendykowska M.

Int J Mol Sci. 2026 Aug 21;27(16):7507. doi: 10.3390/ijms27167507.

Ginsenosides: potential therapeutic implications in neurodegenerative diseases by inhibiting ferroptosis

Liu C, Zhang Y.

Mol Biol Rep. 2026 Aug 29;53(1):1497. doi: 10.1007/s11033-026-12673-2.

α2-3-sialylated glycosphingolipids in neuroinflammation, immunity, and programmed cell death: mechanistic evidence and context-dependent regulation: a comprehensive review

Li X, Li L, Liu X, Liu S, Yang W, Gao J, Kang S, Wang L, Li J, Wang X, Du H, Su S, Li Z, Xu W.

Front Immunol. 2026 Aug 19;17:1865721. doi: 10.3389/fimmu.2026.1865721. eCollection 2026.

Therapeutic potential of apigenin in neurodegenerative diseases and brain health

Aldiqs M, Aliev M, Gajjar TB, Senapati JN, Alhasso B, Urazbaeva D, Aminqulov S, Mishra MK.

Mol Biol Rep. 2026 Sep 5;53(1):1540. doi: 10.1007/s11033-026-12703-z.

The double-edged sentinel: cGAS-STING as a context-dependent regulator of microglial senescence and neuronal genotoxic stress in neurodegeneration

Zhang C, Yang Z.

Brain Res Bull. 2026 Oct 15;245:112118. doi: 10.1016/j.brainresbull.2026.112118. Epub 2026 Sep 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias